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We have demonstrated by several  lines of evidence 
that in platelets myristate is linked to proteins predom- 
inantly via thioester bonds as is palmitate, and the 
covalent binding of the two long chain saturated fatty 
acids to proteins involves the same mechanisms. The 
first piece of evidence to support the thioester linkage 
between myristate and proteins is that [3H]myristate 
could be removed from proteins via alkaline metha- 
nolysis, which disrupts ester bonds but not amide 
bonds. The second piece of evidence is that unlabeled 
palmitate, which can form only thioester bonds in 
physiologic concentrations, competitively inhibits the 
formation of alkaline methanolysis-sensitive covalent 
bonds between [‘Hlmyristate and proteins. Third, by 
SDS-polyacrylamide gel electrophoresis and fluorog- 
raphy, the patterns of labeled proteins from [‘Hlmyris- 
tate- and [‘Hlpalmitate-labeled platelets  are identical. 
Fourth, [‘Hlmyristate-labeled proteins, like [‘Hlpal- 
mitate-labeled proteins, both release their fatty acid 
moieties when exposed to hydroxylamine at neutral 
pH, which disrupts thioester but not hydroxyester 
bonds. These findings indicate that although the cova- 
lent binding of palmitate to proteins was found to occur 
at a faster rate than that of myristate, protein S fatty 
acid acylation that occurs posttranslationally is not 
specific for palmitate. 
A large number of proteins  have been shown  to undergo 
covalent modification  by the  attachment of long chain  satu- 
rated  fatty acids. Fatty acid acylation  confers an  extra  hydro- 
phobic  moiety to  proteins, which  may facilitate  the  binding 
of such proteins to hydrophobic membrane domains and 
promote hydrophobic protein-protein  interactions  (for eview, 
see Refs. 1-4). A fatty acid may be linked  to a protein  through 
an  amide  bond via an  N-terminal glycine moiety cotransla- 
tionally or through a thioester bond via an  internal  (or  C- 
terminal) amino acid posttranslationally. Present evidence 
indicates that the fatty acid involved in the first type of 
modification (amide bond) is myristate, and it is generally 
accepted  that  palmitate  is  the  ester-linked  fatty acid  moiety. 
The enzyme  responsible  for the  covalent  binding of myristate 
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to  proteins,  N-myristoyl  transferase,  has been  purified from 
Saccharomyces cerevisiae and  the gene cloned. This enzyme 
was found to exhibit a strict substrate specificity toward 
myristoyl-CoA as  the  fatty acid donor  and  N-terminal glycine 
as  the  amino acid acceptor (5-10). Much less is known about 
the biochemical mechanism of posttranslational  acylation of 
proteins  with  fatty  acids  through  thioester linkages. Thus  far, 
no palmitoyl transferase activity has been purified, and no 
gene related  to  this  activity  has been cloned. In  addition,  the 
enzymology of this type of fatty acid acylation is poorly 
understood. A great  number of metabolic  labeling experiments 
in which  radiolabeled palmitate became bound  to individual 
proteins via hydroxylamine-sensitive  thioester  linkages have 
provided support  for  the  concept  that  palmitate is the  fatty 
acid  involved in  protein modification through  thioester  link- 
ages,  However, the  results of several studies suggest, but  do 
not conclusively demonstrate,  that  myristate may also become 
bound to proteins via thioester bonds. In certain cell-free 
systems  using  homogenates  rather  than  intact ells, acylation 
through thioester bonds has failed to show high specificity 
with  regard  to  the  chain  length  in  the range of C-14 to  C-18 
(11). Three  studies involving the use of intact cells in culture 
in which the  covalent  binding of different  chain  length  fatty 
acids  to  proteins was analyzed provide  conflicting data  con- 
cerning  chain  length specificity  for thioester-bound  fatty 
acids. In  human  keratinocytes  and  squamous  carcinoma cell 
lines  (12),  as well as  in  BC3H1 muscle cells (13, 14),  little, if 
any,  protein-bound  myristate was found  in  ester linkage, while 
in  3T3 mouse fibroblasts and PC12 rat pheochromocytoma 
cells (13), a minor but significant portion of myristate was 
linked  to  protein via ester, probably thioester, bonds. These 
studies  are  somewhat difficult to  interpret, however, because 
in cells such as these  with  active  protein  synthesis,  both  amide 
and  thioester  linkages  are  constantly being  formed, and  ra- 
diolabeled myristate  incorporation  into  protein could, there- 
fore, be via amide as well as  thioester bonds. Also, fatty acids 
can become covalently  bound  to  proteins  as  the  ester-linked 
fatty acid  moieties of glycosylated phosphatidylinositol  mem- 
brane  anchors (15). This  protein modification by fatty acid is 
a very early  posttranslational  event, is associated with  active 
protein  synthesis (16), and  further  confounds  the  interpreta- 
tion of studies involving cells synthesizing new proteins. 
Nonetheless,  the  study involving cell homogenates (11) and 
the  three involving intact cells (12-14) raise  the possibility 
that  myristate (14:O) can become covalently bound  to  proteins 
by thioester  as well as  amide linkages. To address  this  ques- 
tion definitively, we used  human  platelets, a system with little 
or  no  protein  synthesis. 
We have  previously shown  that  in blood platelets palmitoy- 
lation of proteins via thioester linkages is  an  active process 
(17, 18). In  the  present  study, we investigated  the  covalent 
attachment of myristate  to  platelet  proteins.  The  aims of the 
present study were: 1) to determine whether myristate be- 
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comes linked to platelet proteins; 2) if so, to determine the 
type of linkage(s); and 3) if the linkage is a thioester, to 
compare it qualitatively and quantitatively with palmitoyla- 
tion of platelet  proteins  through  thioester linkages. We found 
that myristate is bound to platelet proteins predominantly 
through thioester linkages, that this binding is effectively 
prevented by excess palmitate,  and that myristate  binds to 
the same set of proteins  as  palmitate. 
EXPERIMENTAL  PROCEDURES 
Materials-[9,10-3H]Myristic acid (39.8 Ci/mmol), [9,10-3H]pal- 
mitic acid (38.0 Ci/mmol), and Formula 989 scintillation solution 
were purchased from Du Pont-New  England Nuclear. [%]Methio- 
nine (1000 Ci/mmol) was obtained from Izinta  (Budapest,  Hungary). 
Unlabeled fatty acids (myristate,  palmitate, and  stearate)  and fatty 
acid methyl esters  (methyl  myristate, methyl palmitate, and methyl 
stearate) were products of Nu-Check Prep (Elysian, MN). Hydrox- 
ylamine, human thrombin (3000 units/mg), apyrase (grade VII), and 
fatty acid-free bovine serum albumin were obtained from Sigma. M. 
marker  proteins were from Bio-Rad. Prostaglandin E, was purchased 
from Advanced Magnetics (Cambridge, MA). "C-Methylated M, 
marker proteins and autoradiographic image enhancer (Amplify) were 
from Amersham Corp. High performance liquid chromatography 
(HPLC)' grade solvents were used for delipidation of proteins,  alka- 
line methanolysis, and extraction of fatty acids. Methanolic HC1 (3 
M) was the product of Supelco (Bellefonte, PA). 
Preparation of fHlMyristate-  and fH1Palmitate-labeled Platelet 
Suspensions-Isolation of platelets for the present  studies performed 
as we described earlier (17) was  followed with minor modifications. 
Platelet-rich plasma was obtained by centrifugation (120 X g, 15 min) 
of human blood anticoagulated with acid-citrate dextrose containing 
0.18 p~ prostaglandin El. Platelets were then pelleted from platelet- 
rich plasma (1300 X g, 15 min) and resuspended in solution A (140 
mM NaCl, 2.5 mM KCl, 0.1 mM MgClZ, 10 mM NaHC03, 0.5 mM 
NaHzP04, 1 mg/ml  glucose, 10 mM HEPES, pH 7.4) containing 3.6 
mg/ml fatty acid-free bovine serum albumin, 1 unit/ml apyrase, 0.3 
p~ prostaglandin El, and 300 pCi/ml [3H]myristate (7.5 p ~ )  with or 
without 30 p~ unlabeled palmitate  or 300 pCi/ml [3H]palmitate (7.9 
p ~ ) .  The platelet count of the platelet-rich plasma was between 300 
and 330 X 106/ml. Labeled and unlabeled fatty acids were dried 
completely under nitrogen and  then solubilized in aqueous medium 
by vortexing for 60 s in the above buffer. After incubation of platelet 
suspensions for 1 or  4  h with various combinations of labeled and 
unlabeled fatty acids, total platelet-associated radioactivity was de- 
termined. Platelets were then pelleted by centrifugation (1100 X g, 
15 min) and resuspended in the same volume of solution A containing 
1 unit/ml apyrase and 0.3 p~ prostaglandin El. Platelets were again 
centrifuged (1100 X g, 15 min) and resuspended in solution A con- 
taining 1 unit/ml apyrase. Aliquots were  removed for the determina- 
tion of platelet count and radioactivity incorporated into platelets. 
The  entire procedure was carried out at 37 "C. During centrifugation, 
the temperature in the centrifuge was maintained between 32 and 
37 "C. As determined in  separate experiments, platelets radiolabeled 
for 1 or  4  h responded effectively to 0.1 unit/ml thrombin when tested 
for aggregation in  a platelet aggregometer (Bio Data,  Horsham, PA). 
Extraction of Noncoualently Bound Lipids-Precipitates from 1 ml 
of washed radiolabeled platelets were generated by addition of 3.5 
volumes of cold acetone (vortexing for 60 s) to  the platelet suspension. 
The precipitates were kept on ice for 30 min, at which time they were 
collected by centrifugation (4500 X g, 0 "C, 10 min). The precipitates 
from the 1-ml platelet suspension were then extracted with 6 ml of 
chloroform/methanol (21).  The mixture was vortexed for 60 s and 
then incubated at  room temperature for 30 min. The precipitate, 
pelleted by centrifugation (4500 X g, room temperature, 15 min), was 
extracted twice more with 6 ml of the same chloroform/methanol 
(2:l) solvent, then twice with 6 ml of chloroform/methanol/water 
(1:1:0.3), and finally with 6 ml of methanol. After each extraction 
step, the samples were left a t  room temperature for 10 min and 
centrifuged as described. The final protein residue contained no 
radioactivity extractable by lipid-extracting solvents, and  it was dried 
completely under nitrogen. Certain samples were dissolved in SDS- 
PAGE sample buffer (without  6-mercaptoethanol) by boiling for 5 
min and  then shaking overnight. The protein content  and radioactiv- 
The abbreviations used are: HPLC, high performance liquid chro- 
matography; PAGE, polyacrylamide gel electrophoresis. 
ity of the samples were determined. Other samples were used for 
HPLC. 
identification and quantitation of fatty acids bound to proteins by 
Release of Protein-bound Fatty Acid and Identification of Released 
Fatty Acids by HPLC-The dried delipidated protein preparations 
were first subjected to alkaline methanolysis to disrupt  ester linkages. 
In  this process, the delipidated protein was treated with 2 ml  of  0.2 
M KOH in  methanol for 30 min at  37 "C and  then centrifuged (4500 
X g, room temperature, 10 min). The supernatant was removed, 
acidified with 2 M HCl, and  the  fatty acid methyl esters generated by 
this procedure were extracted three times with 1.5  ml  of hexane each 
time. Approximately 95% of the radioactivity released by methanolic 
KOH was recovered in the combined hexane extract. This extract 
was then dried completely under nitrogen and redissolved in metha- 
nol. Aliquots were removed for determination of extracted radioactiv- 
ity before HPLC analysis. At this point, 150 pg of each unlabeled 
fatty acid (myristate, palmitate, stearate) and corresponding unla- 
beled fatty acid methyl esters were added to  the samples as standards. 
Separation of the  three fatty acids and  three fatty acid methyl esters 
as six separate peaks was achieved by reverse-phase HPLC using a 
Microsorb C18 column (4.6 mm X 30 cm) (Rainin, Woburn, MA). 
The fatty acids were eluted with 94% acetonitrile, 17 mM phosphoric 
acid (v/v) for 24 min and  then with 97% acetonitrile, 17 mM phos- 
phoric acid (v/v) for 12  min at a flow rate of 1 ml/min. Fractions of 
1 ml were collected and counted in  4 ml of scintillation fluid. The 
absorbance profile of eluted compounds was monitored at 205 nm, 
and retention times of radioactive alkaline methanolysis products 
were determined by coelution with unlabeled fatty acid and fatty acid 
methyl ester  standards. 
After the removal of alkaline methanol, the protein pellet was 
washed with 2 ml of methanol and  then subjected to acid methanolysis 
to release any amide-bound fatty acid. The samples were treated with 
2 ml of 3 M methanolic HCl at 110 "C for 48 h under nitrogen. The 
reaction solutions were extracted three times with 1.5  ml of hexane, 
and the combined hexane fractions were processed for HPLC as 
described above for alkaline methanolysis products. The radioactivity 
that was not released by alkaline or acid methanolysis was also 
determined. 
SDS-PAGE, Hydroxylamine Treatment, and Fluorography of Poly- 
acrylamide Gels-The platelet protein pellet recovered by acetone 
precipitation was washed with another volume of cold acetone, dried, 
and dissolved in  SDS-PAGE sample buffer (half the volume of the 
final platelet suspension). In certain experiments, radiolabeled plate- 
lets  not exposed to acetone were also pelleted and dissolved directly 
in sample buffer. Acetone treatment did not remove any radiolabeled 
platelet  proteins, since with or without acetone there was no differ- 
ence in the protein or fluorographic pattern following  gel electropho- 
resis. Samples in the solubilizing buffer for SDS-PAGE were either 
reduced with 50 mg/ml 0-mercaptoethanol for 1 h at room tempera- 
ture or processed without reduction. SDS-PAGE was performed on a 
5-20% gradient gel according to  the method of Laemmli (19). After 
electrophoresis, the gels  were first fixed in a 50% ethanol, 5% acetic 
acid solution for 45 min and stained as previously described (18). 
Selected fixed gels  were washed three times for 10 min (each wash) 
in distilled HzO and treated for 12 h at room temperature with 1 M 
hydroxylamine, pH 7.0 (to disrupt thioester linkages), or with 1 M 
Tris-HC1, pH 7.0 (as a  control). Hydroxylamine or Tris was  removed 
by rinsing the gel three times for 10 min (each wash) in distilled HzO. 
The gels  were then stained and destained. Destained gels  were soaked 
in Amplify solution supplemented with 1% glycerol for 1 h, briefly 
rinsed with distilled HzO, and dried at 60 "C. The dried gels were 
exposed to Kodak X-Omat AR film (Rochester, NY) at -70 "C for  4 
days or  4 weeks. As determined in  separate experiments, staining and 
destaining did not decrease the intensity of radiolabeled bands  on the 
fluorograms to any significant extent; treatment with Tris-HC1 or 
hydroxylamine did not result in any change in the protein patterns 
on the gel, and Tris-HC1 had no effect on the fluorograms. Reduced 
and unreduced samples were run either on separate gels prepared 
from the same acrylamide gradient or, if they were run on the same 
gel, the reduced and unreduced samples were separated from each 
other by at least eight lanes to prevent even minimal contamination 
of unreduced samples with the 0-mercaptoethanol in the wells with 
reduced samples. 
Metabolic  Labeling of Platelets with f6S]Methionine and the Deter- 
mination of Trichloroacetic  Acid-precipitable  Radioactiuity-Labeling 
of platelets with 300 pCi/ml [36S]methionine was performed exactly 
as described for 3H-labeled fatty acids. For determination of total 
protein-bound 35S, 200 pl of platelet suspension was treated for 10 
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min with 4 ml of 10% boiling trichloroacetic acid, and then the 
precipitate was washed three times with 10% trichloroacetic acid. 
The  final  precipitate was dissolved  in  0.1 M NaOH  and the protein 
and  radioactivity in the  precipitate  quantitated. 
Other Methods-Protein concentration was measured with the 
BCA protein assay kit (Pierce Chemical Co.). Radioactivity was 
counted in a Beckman Instruments LS 6800 scintillation counter. 
RESULTS AND DISCUSSION 
Uptake of Fatty Acids into Platelets and Covalent Binding 
to Proteins-Platelets incorporated a significant portion of 
the  total added myristate (6.20 f 0.15%, 1.55 nmol of myristic 
acid/lOg platelets)  after  4 h. The fact that unlabeled palmitate 
competed to a significant extent with the uptake of [3H] 
myristate  into  platelets (Fig. 1) is  consistent with the concept 
that  the incorporation of the two fatty acids into platelets 
involves similar mechanisms. Studies involving the esterifi- 
cation of different fatty acids into  platelets (20) have indicated 
that  there are two fatty acid uptake systems in  platelets, one 
for eicosanoid precursor fatty acids and one for all other  fatty 
acids including myristate  and  palmitate. We observed, how- 
ever, that  the  rate of uptake of myristate was approximately 
3-fold lower than  that of palmitate, suggesting that among 
the  saturated  fatty acids, there  are preferred fatty acid sub- 
strates for uptake  into platelets. 
A small portion of incorporated [3H]myristate became co- 
valently attached to platelet  proteins  (Table I),  as indicated 
by the fact that  it remained associated with the protein residue 
even after exhaustive lipid extraction  or  treatment with SDS. 
This was similar to our earlier finding with [3H]palmitate 
(18). The amount of protein-linked  myristate in disintegra- 
tion/min/ng of protein was significantly less than that of 
palmitate (0.13 f 0.01 versus 1.93 +- 0.11 at 1 h  and 0.34 f 
0.01  versus 4.10 f 0.32 at 4  h for a 12-15-fold difference). The 
results suggest that  this difference is not likely to be only a 
result of the lower rate of uptake of [3H]myristate versus [3H] 
palmitate @-fold difference in  uptake versus  12-15-fold dif- 
ference in fatty acid acylation). The same percentage of 
incorporated radioactivity was found to be protein bound after 
1 and 4 h of incubation of radiolabeled fatty acids with 
platelets. Therefore, within this interval at least, the ratio of 
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FIG. 1. Incorporation of ['Hlmyristate (MYR) and ['Hlpal- 
mitate (PALM) into platelets. Platelets were  incubated  with 300 
pCi/ml (7.5 p ~ )  [3H]palmitate, 300 pCi/ml (7.5 p ~ )  [3H]myristate, 
or 300 pci/ml (7.5 pM) [3H]myristate + 30 pM palmitate  for 1 or 4 h, 
and the  total  radioactivity  incorporated  into  platelets was determined. 
The values represent the mean & S.E. of three  experiments. 
TABLE I 
The covalent attachment of incorporated radiolabeled fatty acids to 
platelet  proteins 
Values are mean f S.E. from three  experiments.  The  [3H]myristate 
concentration was 7.5 p ~ ;  [3H]palmitate was 7.9 p ~ ,  and unlabeled 
Dalmitate was 30 UM. 
~~ ~ 
Protein-linked radioactivity 
Fatty acid incubated Time of 
with platelets incubation dpm/ 
% of total dpm 
incorporated 
ng by platelets 
h 
[3H]Myristate 1 0.13 & 0.01 0.53 k 0.03 
[3H]Myristate 4 0.34 k 0.01 0.53 f 0.02 
[3H]Myristate + 4 0.09 k 0.01 0.26 f 0.03 
[3H]Palmitate 
palmitate 
1 1.93 f 0.11 2.12 & 0.12 
r3H1Palmitate 4 4.10 & 0.32  2.05 k 0.16 
on the amount of incorporated 3H-labeled fatty acid. Taken 
together, the results indicate that myristate  can become co- 
valently bound to proteins,  but  palmitate is a preferred sub- 
strate.  The  data in Table  I show that  the addition of unlabeled 
palmitate reduced the covalent binding of [3H]myristate to 
platelet  proteins by  3.7-fold, and  the percentage of protein- 
linked [3H]myristate within the total incorporated radiola- 
beled myristate pool also decreased by 2-fold. This suggests 
that palmitate  and  myristate compete for covalent binding to 
proteins. 
Hydrolysk of Fatty Acids from Proteins and Fatty Acid 
Identification-From the experiments involving fatty acid 
hydrolysis from proteins  (Table II), we determined, as found 
in our previous experiments, that more than 90% of the 
protein-bound radioactivity in [3H]palmitate-labeled cells was 
released by alkaline methanolysis. A much smaller amount 
(2.9%) of total released radioactivity or 49 dpm/Fg platelet 
protein was nonreleasable. In the present experiments, we 
observed that 72.8%  of the [3H]myristate (1 h of incubation) 
was releasable by alkaline methanolysis and, therefore, linked 
to protein via an ester bond ( S -  or 0-ester). We also found 
that 26 dpm/pg platelet  protein was nonreleasable in the [3H] 
myristate-labeled cells. This absolute value was similar to 
that observed for palmitate (26 versus 49 dpmlpg),  but since 
the  total amount of protein-bound radioactivity in the [3H] 
myristate-labeled cells was much smaller, the nonreleasable 
fraction is higher by percentage calculations than in [3H] 
palmitate-labeled cells. Presumably, a fixed small amount of 
labeled fatty acid is 8-oxidized, and  the 3H is removed from 
the  fatty acid molecule and becomes associated with protein 
by another mechanism. Acid methanolysis following alkaline 
methanolysis released only small amounts of additional pro- 
tein-linked radioactivity. Importantly, our results do not in- 
dicate that proteins myristoylated through amide linkages are 
absent in platelets. Active protein synthesis in megakaryo- 
cytes provides the necessary opportunity for such cotransla- 
tional  fatty acid acylation of proteins. Thus, we conclude that 
above a small fixed base-line amount of nonreleasable disin- 
tegrationslmin,  [3H]myristate  in  platelets is largely bound to 
protein by ester linkages. 
TO confirm that amide linkages would survive alkaline 
hydrolysis under the experimental conditions used in our 
studies with platelets, we performed parallel experiments with 
a mouse fibrosarcoma cell line  (HSDMICI) with active protein 
synthesis  and,  thereby, active formation of amide bonds be- 
tween proteins and fatty acids. The labeling conditions for 
the fibrosarcoma cells and  the platelets were identical. We 
found that 30-40% of protein-linked [3H]myristate in fibro- 
sarcoma cells was resistant to alkaline methanolysis but  that 
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TABLE I1 
Analysis of facly  acids  covalently  linked  to proteins in [3Hlmyristate- and PHlpalmitate-labeled platelets 
Values represent means of duplicate experiments, the results of which did not differ from each other by  more than 10%. FA, fatty acid; 
ND, not determined. 
Fatty acid Incubation Released by methanolysis time Nonreleasable Alkaline 
Total 
" -~ Acid 
h dprnlLcg platelet  protein 
[3H]Myristaten 1 83 (72.8%) 5 (4.4%) 26 (22.8%) 114 (100%) 
Myristate' 
Palmitateb 12 (10.5%) ND 
Stearateb 0 
Myristateb 16 (0.9%) 
Palmitate' 1538 (89.8%) ND 
Stearate' 48 (2.9%) 
Myristate' 164 (57.5%) 30 (10.5%) 
Palmitateb 29 (10.2%) 0 
Stearate' 0 0 
Myristateb 21 (27.6%) 10 (13.2%) 
Palmitate' 6  (7.9%) 0 
Stearateb 0 0 
', released FA; (myristate + palmitate + stearate) sums to percentage of labeling FA. 
71 (62.3%) 
[3H]Palmitate" 1 1602 (93.6%) 61 (3.5%) 49 (2.9%) 1712 (100%) 
[3H]Myristate" 4 193 (67.7%) 30 (10.5%) 62 (21.8%) 285 (100%) 
[3H]Myristate + palmitate" 4 27 (35.5%) 10 (13.2%) 39 (51.3%) 76 (100%) 
labeling F A  (alkaline + acid + nonreleasable) sums to 100%. 
2000 1 
3 5 $3 $ 2  I 1500 v v v  v v  ? 2 V 
0 
0 1 0  2 0  30 40 
FRACTION NUMBER 
FIG. 2. Identification  and  quantitative  analysis of radiola- 
beled fatty acids released from proteins of [3H]myristate- 
labeled platelets by alkaline methanolysis. Elution positions of 
myristate (MA), palmitate ( P A ) ,  stearate ( S A ) ,  methyl myristate 
( M M ) ,  methyl palmitate ( M P ) ,  and methyl stearate ( M S )  (arrow- 
heads) were determined by monitoring absorbance at 205 nm. This 
chromatogram is representative of two essentially identical chromat- 
ograms. 
this radioactivity could be released by acid methanolysis.' 
This  result  confirms  that  any  [3H]myristate  bound  to  platelet 
proteins  through  amide linkages, if present, could  have sur- 
vived alkaline methanolysis as expected and supports the 
conclusion that only trace  amounts of [3H]myristate, if any, 
were linked  to  platelet  proteins  via  an amide  linkage. 
The identification of radiolabeled fatty acids released by 
alkaline  and acid methanolysis was carried  out by reverse- 
phase  HPLC  using unlabeled fatty acid and  fatty acid methyl 
ester  standards (Fig. 2). As previously reported (18), in [3H] 
palmitate-labeled platelets, the protein-bound radiolabeled 
fatty acid was almost exclusively thioester-linked  palmitate. 
In  [3H]myri~tate-labeled cells, we found 85% of protein-linked 
3H-labeled fatty acid  released  by alkaline  methanolysis  to  be 
[3H]myristate  (Table 11). The  remaining 15% was  recovered 
as  [3H]palmitate  formed by chain  elongation (21) of the [3H] 
myristate  prior  to  its  attachment  to  proteins.  The  competition 
of unlabeled palmitate using physiologic concentrations of 
* L. Muszbek and M. Laposata, unpublished observations. 
nonesterified palmitate in the plasma (30 P M ) ~  with [3H] 
myristate for protein  binding revealed  a number of important 
observations. While  there was a 2-3-fold change in the  non- 
releasable (62 uersus 39 dpmlpg)  and  amide-linked  (30 uersus 
10 dpm/pg) pools, in the presence of unlabeled palmitate, 
there was an  &fold decrease in  the  ester-linked  [3H]myristate 
pool (164 uersus 21 dpm/pg). These data indicate that in 
platelets, palmitate competes with myristate for binding  to 
proteins  through  thioester linkages. 
SDS-PAGE and Fluorography-The results of our fluoro- 
graphic  experiments  shown  in Fig. 3 indicate  that  as  in  [3H] 
palmitate-labeled cells, nearly  all of the  [3H]myri~tate cova- 
lently linked to platelet proteins was released by neutral 
hydroxylamine treatment.  This  indicates  that  the bulk of the 
protein-bound  [3H]myristate is linked  through  S-ester  link- 
ages rather  than  0-esters. Hydroxylamine at neutral or 
slightly  acidic pH  disrupts  thioester linkages but,  as verified 
with model compounds (22, 23) and  with  the glycosyl phos- 
phatidylinositol  membrane  anchor (15), at  this  pH, hydrox- 
ylamine does not cleave the hydroxyester  linkage. 
Finally, we compared  the  SDS-PAGE  patterns of platelet 
proteins labeled with  [3H]palmitate  with 3H-labeled proteins 
labeled with  myristate.  Due  to less uptake  and less intense 
binding  to  proteins of [3H]myristate-labeled  samples relative 
to  [3H]palmitate-labeled samples, as noted  earlier,  lanes with 
[3H]myristate samples required much longer exposure than 
those  with  [3H]palmitate  to  obtain  comparable  intensity (Fig. 
3). A thorough  comparison of fluorograms  from both reduced 
and unreduced protein samples of homogenates from [3H] 
myristate  and  [3H]palmitate-labeled  platelets howed identi- 
cal fluorographic patterns  after  SDS-PAGE. 
It has been previously shown that the extent of protein 
synthesis  in  the  platelet is insignificant when  compared with 
the  amount of protein  synthesis  in  nucleated cells, with  much 
of the  protein  synthesis  in  these cells  involving  major  cyto- 
skeletal  proteins (24,25). The  amount of acid-precipitable 35S 
radioactivity  in  platelets metabolically  labeled with [35S]me- 
thionine, which  reflects radioactivity  incorporated  into  plate- 
let  proteins, was less than 2% of the  amount  obtained with 
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FIG. 3. ‘H-Myristoylated and ‘H-Palmitoylated proteins in 
platelets. Platelets were washed and labeled with ‘H-labeled fatty 
acid; platelet proteins were precipitated and extracted with acetone, 
then analyzed with SDS-PAGE and fluorography as described under 
“Experimental Procedures.” C, Coomassie Blue staining; M and P, 
fluorogram of proteins from [’Hlmyristate- (4-week exposure) and 
[3H]palmitate- (4-day exposure) labeled platelets, respectively; -HA 
and +HA, gels incubated in the absence or presence of 1 M neutral 
hydroxylamine. To each well, 63 pg of platelet protein was applied. 
Arrows represent the migration distance of standard proteins of the 
following molecular mass, from top to bottom: 200, 116,97.4, 66.2, 45, 
31, 21.5, and 14.4 kDa. 
mononuclear peripheral blood cells. The value obtained  using 
35S-labeled platelets was 0.99 f 0.03 dpm/ng protein (1-h 
incubation, mean k S.E., n = 3). The  results of this  control 
study support the conclusions that  little, if any, cotransla- 
tional  binding of myristate  to  proteins  occurs in platelets via 
amide linkages and  that  myristate  is  linked  to  platelet  pro- 
teins  posttranslationally via thioester bonds. 
We  have  proven by several lines of evidence in  this  study 
that  myristate  can indeed be linked to  proteins via thioester 
bonds in a cell system where there is little or no protein 
synthesis  and,  therefore,  as  our  data  support,  no active for- 
mation of amide  bonds between myristate  and cell proteins. 
The  posttranslational  binding of myristate  and  palmitate  to 
proteins in platelets apparently involves identical mecha- 
nisms, and  the two fatty acids become bound  to  the  same  set 
of substrate proteins. These findings strongly support the 
view that, as far as chain length of saturated fatty acid is 
concerned, fatty acid  acylation of proteins  through  thioester 
linkage is of somewhat relaxed specificity. Therefore,  instead 
of the generally used term, palmitoylation, protein S fatty 
acylation would be a more accurate term to describe this 
process. 
We observed that modification of platelet proteins with 
[3H]myristate occurred a t  a lower rate  than  with  [3H]palmi- 
tate.  There  are several  possible explanations for this obser- 
vation.  Proteins S fatty acyl transferase(s) may have a lower 
affinity for  myristoyl-CoA than palmitoyl-CoA. A slower rate 
of myristoyl-CoA synthesis  or a  higher rate of deacylation of 
thioester-linked myristate by a protein-fatty acylase could 
also be responsible for this difference. In the plasma, the 
nonesterified palmitate concentration is much higher than 
the nonesterified myristate  concentration.  We  have found in 
our  laboratory  that  the  nonesterified  palmitate  concentration 
in  the  plasma  is 30.5 k 16.5 PM, and  the nonesterified  myris- 
tate concentration is 2.3 f 1.5 pM (mean & S.D., n = 11 
different nonfasting  individual^).^ Because of the relative 
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abundance of the two fatty acids in the plasma and the 
preferential  uptake of palmitate over myristate  into  the  plate- 
lets, we suggest that in vivo palmitate is much  more likely to 
be bound to proteins by thioester linkages than myristate, 
although  both  fatty acids can be thioester linked to proteins. 
There may be  a  much greater complexity  in the process of 
fatty acid acylation via thioester bonds than is presently 
understood.  It  has been  shown that  this  type of posttransla- 
tional modification involves a t  least two distinct classes of 
target  proteins for fatty acid binding. One  class  includes the 
proteins localized to  the  inner surface of the plasma mem- 
brane, which are  resistant  to  extraction procedures that  usu- 
ally  release peripheral  membrane  proteins (26-29). The  other 
set of proteins includes transmembrane  proteins  or glycopro- 
teins  in which the  fatty acid is linked to a cysteine residue 
located just below the hydrophobic transmembrane domain 
in  the cytoplasmic region (18, 30-32). It  has been suggested 
that fatty acids might be thioester linked to proteins by 
different  fatty acyl transferases located in different  subcellu- 
lar compartments. Indeed, plasma membrane, endoplasmic 
reticulum, Golgi apparatus,  and cytoplasm  have all been sug- 
gested as  sites where posttranslational  fatty acid acylation of 
proteins  can  take place (1-4). Our data raise the possibility 
that  different  fatty acyl transferases  are responsible for the 
protein  binding of myristate and palmitate via thioester 
bonds. The hydrophobicity of the  fatty acid moiety is clearly 
a critical factor in the functional modification of certain 
proteins. Since hydrophobicity is greatly affected by differ- 
ences  in carbon  chain  length,  the issue of fatty acid specificity 
for protein modifications, as addressed in this study, may 
have major functional implications. 
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